These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23543036)

  • 1. Sodium valproate induced increased frequency of micturition and enuresis.
    Gosavi DD; Suman A; Jain M
    Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced enuresis: a prospective study.
    Yamak WR; Hmaimess G; Makke Y; Sabbagh S; Arabi M; Beydoun A; Nasreddine W
    Dev Med Child Neurol; 2015 Aug; 57(8):737-41. PubMed ID: 25808512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-induced worsening of seizures: clue to underlying diagnosis.
    Dhamija R; Gavrilova RH; Wirrell EC
    J Child Neurol; 2011 Oct; 26(10):1319-21. PubMed ID: 21454832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal enuresis associated with sodium valproate.
    Panayiotopoulos CP
    Lancet; 1985 Apr; 1(8435):980-1. PubMed ID: 2859433
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium valproate and enuresis.
    Choonara IA
    Lancet; 1985 Jun; 1(8440):1276. PubMed ID: 2860475
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum drug level-related sodium valproate-induced hair loss.
    Ramakrishnappa SK; Belhekar MN
    Indian J Pharmacol; 2013; 45(2):187-8. PubMed ID: 23716898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety, tolerability, and efficacy of magnesium valproate versus sodium valproate in acute seizures.
    Peng X; Yan Y; Chen R; Wang X; Xu X
    Curr Med Res Opin; 2020 Feb; 36(2):271-276. PubMed ID: 31775535
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized onycholysis associated with sodium valproate therapy.
    Grech V; Vella C
    Eur Neurol; 1999 Jul; 42(1):64-5. PubMed ID: 10523137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observation of valproate sodium-induced nocturnal enuresis].
    Yokoyama A; Saito Y; Maegaki Y; Ohno K
    No To Hattatsu; 2007 May; 39(3):227-8. PubMed ID: 17515140
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous Levetiracetam and Sodium Valproate Use in Palliative Care Patients.
    Kondasinghe JS; Look ML; Moffat P; Bradley K
    J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):228-232. PubMed ID: 35930500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on sodium valproate.
    Rimmer EM; Richens A
    Pharmacotherapy; 1985; 5(3):171-84. PubMed ID: 3927267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate induced isolated neutropenia.
    Kohli U; Gulati S
    Indian J Pediatr; 2006 Sep; 73(9):844. PubMed ID: 17006050
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sodium valproate in 100 children with special reference to weight.
    Egger J; Brett EM
    Br Med J (Clin Res Ed); 1981 Aug; 283(6291):577-81. PubMed ID: 6790086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual cutaneous reaction with sodium valproate.
    Roy S; Goel D
    Neurol India; 2009; 57(2):216-7. PubMed ID: 19439862
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium valproate-induced Fanconi type proximal renal tubular acidosis.
    Knights M; Thekkekkara T; Morris A; Finlay E
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.